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Alzheimer’s disease (AD) is an age-linked disease which involves cognitive impairment as a result of
neurodegeneration. The formation of beta-amyloid fibrils in between neurons is a major mechanism
contributing to this disease pathology. The formation and degradation of these proteins have been a
major target in research for this debilitating disease. Natural compounds have been shown to have anti-
amyloidogenic properties and have gained popularity within certain niches. The following natural
compounds were added during in vitro amyloidogensis, using bovine gamma globulin (GG) and hen egg
white lysozyme (HEWL) as a model system: Epigallocatechin-3-gallate (EGCG), a bioactive compound
found in green tea extract; nordihydroguaiaretic acid (NDGA), an antioxidant found in the creosote bush;
phloretin (PHL), an antioxidant flavonoid in apples; and ellagic acid (EA), a polyphenol and a natural
dimeric derivative of gallic acid that is found in fruits and nuts like grapes, strawberries, raspberries, and
walnut. Incubation of these solutions and fluorescence analysis using thioflavin-T (ThT) fluorescence
revealed a linear dose-dependent response for EGCG when fluorescence was plotted against
concentrations of 0, 1, 2, 5, and 10 mM EGCG in HEWL and a hyperbolic dose-dependent response for
GG. The coefficient of determination for 1 mg/mL and 2 mg/mL HEWL with EGCG, respectively was
0.9745 and 0.9679. The excitation wavelength used was 440 nm with an emission wavelength of 480
nm. In 2 mg/mL GG, percent activation for 1, 2, 5, and 10 mM EGCG when compared to the control (0
mM) was 114, 186, 990, and 420%, respectively. For 2 mg/mL HEWL, percent activation for 1, 2, 5, and
10 mM EGCG when compared to the control (0 mM) was 117, 134, 221, and 450%, respectively.
Fluorescence was also noted to be less for HEWL than for GG as the average fluorescence for the first
two hours of analysis for the control 2 mg/mL HEWL was 33.23 and was 989.52 for 2 mg/mL GG under
the same conditions. No relationships were observed for NDGA, PHL, and EA. Circular dichroism (CD)
data was used to show the composition of secondary structure in GG and HEWL. Both of these proteins
with inhibitors of PHL and EA indicated that most of GG’s secondary structure has changed to random
coil structure and most of HEWL’s secondary structure has remained alpha-helical. The presence of
PHL and EA during incubation did not affect the secondary structure of GG and HEWL. There is no
available CD data for EGCG and NDGA due to time constraints, but may be explored in the future.
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The formation of beta-amyloid fibrils within the human brain has been of interest as their characterization has been seen to
contribute to diseases such as Parkinson’s and Alzheimer's Disease (AD). Formation starts with monomers which then
aggregate to form an oligomeric intermediate. Mature fibrils form when these intermediates conjugate.1 These fibrils are
insoluble fibrillary polypeptide aggregates predominantly composed of β-sheet structure in a characteristic cross-β
conformation.2,3 These mature fibrils comprised of beta-sheet protein structure have a stronger tendency to stack upon one
another and aggregate. The kinetic networks of the fibrils are continually being produced and undergo fibrinolysis, however,
when the balance is lost, the fibrils are deposited extracellularly and neurodegenerative diseases such as AD—the most
common form of dementia—can develop.4 Fibrils aggregating between neurons interfere with neural signaling and
communication which leads to the symptoms seen in AD such as memory loss and confusion.
Because of the prevalence of diseases caused by beta-amyloid fibrils, inhibiting the formation of these disease causing proteins
has gained popularity. Finding natural inhibitors of fibril formation has appealed to the general population as they can be
proactive in preventing a potential disease and it can be more appealing than other pharmacologic interventions. Naturally
occurring polyphenols can aid in anti-amyloidogenic drug design because they are known for their antioxidant and anti-
inflammatory properties and they possess a variety of structural backbones. In this study, beta-amyloid fibrils formed using
bovine gamma globulin (GG) and hen egg white lysozyme (HEWL) in vitro were subjected to different concentrations of four
common polyphenols—epigallocatechin-3-gallate (EGCG), nordihydroguaiaretic acid (NDGA), phloretin (PHL), and ellagic acid
(EA).
EGCG (Figure 1) is a naturally occurring polyphenol found in green tea. Along with its antioxidant properties, EGCG has anti-
aggregation properties which inhibit the formation of beta-amyloid fibrils. The formation of covalent adducts when nucleophilic
thiol/amino groups bind to electrophilic carbonyl groups also affects the binding affinity of EGCG to the fibril.5 Additionally, non-
covalent interactions allows EGCG to bind directly to the fibril and remodel previously existing fibrils into less toxic insoluble
aggregates and prevent the formation of toxic oligomers.6,7 Hydrophobic and hydrogen bonding interactions mediate this
activity.
NDGA (Figure 2) is an antioxidant produced as the main metabolite of the creosote bush. This polyphenol has similar
mechanisms to EGCG in binding the pre-formed fibril and contribute to its degradation. A study by Ono and colleagues
demonstrated that NDGA inhibited beta-amyloid fibril formation from APP (1-40) and APP (1-42) and it destabilized pre-formed
fibrils dose-dependently.8 A suggested mechanism for this involves the binding of NDGA’s two ortho-dihydroxylbenzene rings to
free fibrils and preventing their aggregation. The structure could also be suitable for the breakdown of beta-sheets.
PHL (Figure 3) is a polyphenol mainly found in apples and strawberries. Among its antioxidant properties, PHL has also been
found to inhibit fibril formation by decreasing the association of beta-amyloid peptides to the membrane. Studies have shown
that beta-sheet structures are more prevalent in the presence of negatively charged lipid vesicles.9,10 PHL is lipophilic and
dipolar so it decreases the membrane dipole potential. Thus, the negative charge of the lipid membrane is decreased and will
therefore decrease the association of beta-amyloid peptides.11
EA (Figure 4) is a polyphenol and a natural dimeric derivative of gallic acid that is found in fruits and nuts like grapes,
strawberries, raspberries, pomegranate, and walnut. Along with its antioxidative properties, EA has been shown to inhibit fibril
formation by interfering with the fibril formation pathway. One study demonstrated that EA inhibited neuronal death and beta-
amyloid formation on APP/PS1 mice, which are mice that experience pathological similarities with patients that experience
AD.12 Another study found that EA reduced the presence of inflammatory cytokines produced by NF-kB and TLR signaling
pathways what the presence of beta-amyloid fibrils exacerbate.13
The beta-amyloid fibrils formed with GG and HEWL combined with the four aforementioned natural inhibitors were
characterized by thioflavin T (ThT) fluorescence and circular dichroism (CD) spectrometry. ThT will only fluoresce when bound
to beta-amyloid structures, not when bound to monomers or oligomeric intermediates. This will signify that there are beta-fibrils
formed in the controls. When ThT binds the beta sheet, it restrict the bond rotation between the benzthiazole ring and
aminobenzene ring. This results in an excitation at 440 nm and emission at 480 nm.14 (Figure 5)
CD spectrometry is commonly used to study the secondary structure of a protein due to the difference in the absorbance of
circular polarized lights. In essence, it is the differential absorption of left-handed and right-handed light. Two possible spin
angular momentum states are represented by the polarized light which can therefore determine presence of ordered peptide
bonds in the protein secondary structure results in a distinct CD spectrum. Alpha helices have three CD bands—one positive
and two negative. Beta sheets exhibit two CD bands—one positive and one negative. Lastly, random coils have a strong
negative CD band and a weaker positive CD band. Each band is expressed in a specific wavelength alpha-helix shows two
negative bands at 222 nm and 208 nm. Beta-sheet shows one negative band at 218 nm. The random coil structure shows a
negative band at 195 nm (Figure 6).
RESULTS
Figure 7: Dose-Dependent Response of EGCG added to HEWL.
Fluorescence was averaged from one to two hours for each
concentration of added inhibitor during the reading and was plotted
against varying concentrations of EGCG. An increasing linear
response was observed displaying a coefficient of determination of
0.9745and 0.9679 for 1 mg/mL and 2 mg/mL HEWL,
respectively. For 2 mg/mL HEWL, percent activation for 1, 2, 5, and
10 mM EGCG when compared to the control (0 mM) was 117, 134,
221, and 450%, respectively.
EGCG
CD Spectra
Figure 9: Dose-Dependent Response of NDGA added to HEWL.
Fluorescence was averaged from one to two hours for each
concentration of added inhibitor during the reading and was plotted
against varying concentrations of NDGA. No dose-dependent
responses for both 2 mg/mL and 1 mg/mL HEWL were observed.
Figure 11: Dose-Dependent Response of PHL added to
HEWL. Fluorescence was averaged from one to two hours for each
concentration of added inhibitor during the reading and was plotted
against varying concentrations of PHL. No dose-dependent
responses for both 2 mg/mL and 1 mg/mL HEWL were observed.
Figure 13: Dose-Dependent Response of EA added to HEWL.
Fluorescence was averaged from one to two hours for each
concentration of added inhibitor during the reading and was plotted
against varying concentrations of EA. No dose-dependent
responses for both 2 mg/mL and 1 mg/mL HEWL were observed.
Figure 15: CD spectra for HEWL. Saline, PHL, and EA were used as controls to ensure that they are not
optically active. HEWL after incubation without any inhibitor shows a positive CD band around 195 nm and two
negative CD bands at 208 nm and 222 nm. Incubation in the presence of PHL and EA did not seem to change
the secondary structure of HEWL.
Figure 8: Dose-Dependent Response of EGCG added to GG.
Fluorescence was averaged from one to two hours for each
concentration of added inhibitor during the reading and was plotted
against varying concentrations of EGCG. An increasing hyperbolic
response was observed for both 2 mg/mL and 1 mg/mL GG. In 2
mg/mL, percent activation for 1, 2, 5, and 10 mM EGCG when
compared to the control (0 mM) was 114, 186, 990, and 420%,
respectively.
.
Figure 10: Dose-Dependent Response of NDGA added to
GG. Fluorescence was averaged from one to two hours for each
concentration of added inhibitor during the reading and was plotted
against varying concentrations of NDGA. No dose-dependent
responses for both 2 mg/mL and 1 mg/mL GG were observed.
Figure 12: Dose-Dependent Response of PHL added to GG.
Fluorescence was averaged from one to two hours for each
concentration of added inhibitor during the reading and was plotted
against varying concentrations of PHL. No dose-dependent
responses for both 2 mg/mL and 1 mg/mL GG were observed.
Figure 14: Dose-Dependent Response of EA added to GG.
Fluorescence was averaged from one to two hours for each
concentration of added inhibitor during the reading and was plotted
against varying concentrations of EA. No dose-dependent
responses for both 2 mg/mL and 1 mg/mL GG were observed.
Figure 16: CD spectra for GG. Phosphate buffer, PHL, and EA were used as controls to ensure that they are 
not optically active. GG before incubation without any inhibitor shows a positive CD band at 218 nm and a 
negative CD band from 210-225 nm. After incubation, there is a decrease at 200-205 nm in GG without any 
inhibitor. Incubation in the presence of PHL and EA did not seem to change the secondary structure of GG when 
compared to the GG after incubation without any inhibitor.Figure 6: CD spectra of 
secondary structure in 
proteins.15
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Neurodegenerative diseases such as AD are of increasing concern; therefore, new ways are being
explored to seek treatment or prevent certain ailments related to the formation of amyloid fibrils. This
study aimed to explore the anti-amyloidogenic properties of natural polyphenols on GG and HEWL as a
model system.
Both GG and HEWL experienced an increasing dose-dependent response when added with EGCG. The
most fluorescence was observed at the highest concentration of inhibitor. Although this is contradictory to
the expected, it may result from EGCG binding to the fibril to stabilize it to increase the fluorescence
intensity. Therefore, the higher the concentration of EGCG, the more fluorescence (Figure 7). The
relationship between fluorescence and EGCG concentration in HEWL is linear with a the coefficient of
determination 0.9745 and 0.9679 for 1 mg/mL and 2 mg/mL HEWL with EGCG, respectively (Figure 7).
GG experience a hyperbolic relationship, but still maintained an increasing dose-dependent response for
EGCG (Figure 8).
In 2 mg/mL GG, percent activation for 1, 2, 5, and 1 0mM EGCG when compared to the control (0 mM)
was 114, 186, 990, and 420%, respectively (Figure 8). For 2 mg/mL HEWL, percent activation for 1, 2, 5,
and 10 mM EGCG when compared to the control (0 mM) was 117, 134, 221, and 450%, respectively
(Figure 6). This further demonstrates that EGCG activates the fibrils more than the control. Even though it
is observed that EGCG binds to the fibril, it also conveys EGCG toxicity. With increased amounts of
EGCG, some studies have seen hepatotoxicity in mice with too much oral intake.16
Since native GG is comprised of primarily beta sheets, it was noted that ThT fluorescence was more
readily increased than that of HEWL which is comprised more of alpha helices than beta sheets. ThT
binds to amyloid and gives a stronger fluorescence signal. Therefore, fluorescence was noted to be less
for HEWL than for GG as the average fluorescence for the first two hours of analysis for the control 2
mg/mL HEWL was 33.23 and was 989.52 for 2 mg/mL GG under the same conditions after 12 hours of
incubation (Figures 7 and 8).
There was no dose-dependent relationship noted for NDGA, PHL, and EA in both HEWL and GG (Figures
9-14). All varying concentrations gave the same signal indicating that there was no relationship. NDGA is
known to directly bind to amyloid fibril but does not appear to stabilize amyloid. PHL and EA are not
directly involved in binding to the fibrils to inhibit fibril formation—they are just involved in the pathway of
fibril formation and degradation. Therefore, if PHL and EA cannot bind to the formed fibrils, they will have
no effect on the signal like what was observed in EGCG.
Circular dichroism (CD) data was used to show the composition of secondary structure in GG and HEWL.
HEWL after incubation without any inhibitor shows a positive CD band around 195 nm and two negative
CD bands at 208 nm and 222 nm (Figure 15). This is indicative of alpha helical secondary structure. The
presence of PHL and EA did not seem to affect the secondary structure. GG before incubation without any
inhibitor shows a positive CD band at 218 nm and a negative CD band from 210-225 nm. After incubation,
there is a decrease at 200-205 nm in GG without any inhibitor (Figure 16). This indicates that most of
GG’s native secondary structure has unfolded and changed to random coil structure. The presence of
PHL and EA during incubation did not affect the secondary structure of GG as well. It would be suggested
to perform CD data at a lower concentration of 0.01 mg/mL to reduce the noise seen in the 190-200 nm
region of both spectra. However, there were still beta sheets formed in both HEWL and GG because ThT
was able to bind and produce a fluorescence signal indicating the formation process of amyloid is
kinetically a very slow process and 12 hours of incubation was not sufficient to convert most of native
proteins to amyloid.
This study determined the effects of polyphenols on formation of amyloid fibrils. EGCG showed an unexpected
increase in the ThT fluorescence when plotted against increasing concentrations of EGCG. This dose-
dependent response was observed in both GG and HEWL perhaps because EGCG is able to bind to the formed
fibril and stabilize the structure. NDGA, PHL, and EA showed no interaction with the formed fibrils in both GG
and HEWL. ThT fluorescence was higher for GG than it did for HEWL because of the higher beta sheet content
in its secondary structure in GG appeared to accelerate the amyloid formation. CD spectrometry showed GG’s
structure to have changed to random coil and HEWL structure to remain predominantly alpha helical. Longer
incubation at pH 2 would be recommended to form more beta-amyloid structures. Running the CD spectra with a
concentration of protein at 0.01 mg/mL would also be recommended to reduce the noise seen in the spectra.
Future studies should further test other common polyphenols that are known to bind directly to formed amyloid
or prevent the formation by binding to intermediates. CD spectrometry of protein incubated in the presence of
EGCG would be highly recommended as well.
NDGA
PHL EA
All compounds were obtained from Sigma-Aldrich. 10 mg/mL stock solutions of GG and HEWL were prepared (4 mL each). Concentrations of 1, 2, 5, and 10 mM were then prepared for each natural
inhibitor (4 mL). 2 mg/mL solutions of protein were prepared using 10 mg/mL stock protein (0.2 mL), pH 2 phosphate buffer (0.7 mL), and the respective concentration of a specific inhibitor (0.1mL). 1
mg/mL solutions of protein were made by using 10 mg/mL stock protein (0.1 mL), pH 2 phosphate buffer (0.7 mL), and the respective concentration of a specific inhibitor (0.1 mL). pH 2 saline solution was
used in place of pH 2 phosphate buffer for solutions containing HEWL as the protein to ensure favorable conditions for protein aggregation. 2 mg/mL controls were made by using 10mg/mL stock protein
(0.2mL), pH 2 phosphate buffer (0.7 mL), and filter sterile water (0.1 mL). 1 mg/mL controls were made by using 10 mg/mL stock protein (0.1 mL), pH 2 phosphate buffer (0.7 mL), and filter sterile water (0.2
mL). All solutions were filter sterilized and then incubated at 60°C for 12 hours and shaking at 100 rpm.
Solutions were plated in triplicate in a 96 well opaque microplate. A stock solution of ThT was created by dissolving 5 mg ThT in 5 mL pH 2 phosphate buffer. The solution was filter sterilized and was placed
in each well using a multichannel pipette (0.01 mL). ThT fluorescence was monitored using a Molecular Devices SpectraMax M5 microplate reader by excitation at 440 nm and emission at 480 nm every 10
minutes for 12 hours.
The CD spectrum in the far-UV region (190 - 260 nm) of a protein sample was obtained using 3 mL of solution containing 0.05 mg/mL protein using the Jasco J-815 CD spectrometer. The saline solution,
acetate/phosphate buffer, PHL and EA solutions were used as controls to determine whether or not they have a high absorbance in this region of the spectrum.
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